The present study demonstrated that valproic acid (VPA) transcriptionally regulates human GM3 synthase (hST3Gal V), which catalyzes ganglioside GM3 biosynthesis in ARPE-19 human retinal pigment epithelial cells. 
INTRODUCTION
Valproic acid (VPA), a short chain fatty acid, is widely used for the treatment of epilepsy and bipolar disorders due to its anticonvulsant activity (1) . VPA possesses anti-cancer activity through several mechanisms, including inhibition of cell growth, induction of differentiation, and apoptosis (2, 3) .
Gangliosides, sialic acid-containing glycosphingolipids, are ubiquitous components located in the outer leaflet of the plasma membrane of vertebrate cells and play an important role in a variety of biological processes, including in cell-cell interactions, adhesion, subcellular targeting, growth control, and receptor function (4, 5) . In addition, it is well known that the composition and distribution of gangliosides in cells dramatically change during various physiological and pathological processes, such as cell proliferation and differentiation, cell death, development, and oncogenesis (4, 5) . These changes reflect the differential regulation of ganglioside biosynthesis catalyzed by a family of glycosyltransferases in the Golgi apparatus. Recently, we demonstrated that VPA modulates the mRNA expression of human GM3 synthase (hST3Gal V) and GD3 synthase (hST8Sia I) in human neuroblastoma cells (6, 7) .
In the present study, we investigated whether or not VPA transcriptionally regulates hST3Gal V and hST8Sia I, key regulatory enzymes in the synthesis of nearly all gangliosides, in human retinal pigment epithelial cells. As a result, we have shown for the first time that the mRNA expression of human GM3 synthase (hST3Gal V) is induced by VPA in ARPE-19 human retinal pigment epithelial cells. Furthermore, to investigate the molecular basis of hST3Gal V gene expression induced by VPA in ARPE-19 cells, the promoter region directing the up-regulation of reporter gene transcription in ARPE-19 cells in response to VPA was functionally characterized.
RESULTS AND DISCUSSION

Expression of hST3Gal V gene induced by VPA in ARPE-19 cells
Initial experiments were designed to determine whether or not inducers of cell differentiation or apoptosis modulate the expression of human sialyltransferase genes responsible for ganglioside biosynthesis in ARPE-19 cells. After cells were treated with four different inducers (RA, FenR, TPA, and VPA), we examined the gene expression of human GM3 synthase (hST3Gal V) and human GD3 synthase (hST8Sia I), which are especially key enzymes in the ganglioside biosynthesis pathway. As shown in Fig. 1A , the RT-PCR results show that the mRNA expression of hST3Gal V was 2.4-fold higher in cells treated with 1 mM VPA compared to untreated cells, whereas hST8Sia I expression did not change in response to treatment with inducers. The induction of hST3Gal V mRNA expression re-http://bmbreports.org markably increased in response to 1 mM VPA treatment for 6 h and continued for 48 h after VPA treatment (Fig. 1B) . These results clearly show that the expression of hST3Gal V is stimulated by VPA.
Expression of ganglioside GM3 in ARPE-19 cells induced by VPA
To investigate whether or not hST3Gal V mRNA induction by VPA increases the cellular expression level of ganglioside GM3, we used immunofluorescence confocal microscopy with mouse anti-GM3 monoclonal antibody and FITC-conjugated goat-anti-mouse IgM as the secondary antibody to visualize GM3 expression in ARPE-19 cells induced by VPA. As shown in Fig. 2 , increased expression of ganglioside GM3 was observed in ARPE-19 cells induced by VPA but not in the control without VPA treatment. Previous studies have shown that VPA induces apoptosis and differentiation of neuroblastoma cells both in vivo and in vitro (8, 9) . Based on these observations, the effect of VPA on the morphology of ARPE-19 cells was investigated. The results show that 24 h treatment with 1 mM VPA had no effect on cell morphology (data not shown).
Analysis of transcriptional activity of hST3Gal V promoter induced by VPA in ARPE-19 cells
To understand the transcriptional regulation of the hST3Gal V gene in VPA-induced ARPE-19 cells, luciferase constructs (10-12) carrying a 5'-deleted hST3Gal V promoter were transfected into ARPE-19 cells with or without VPA, and the luciferase activity was measured. As shown in Fig. 3A , transfection of pGL3-177 resulted in a remarkable increase in promoter activity in ARPE-19 cells with VPA treatment, which was higher (about 2-fold) than that in ARPE-19 cells without VPA treatment. However, the promoter activity did not change markedly when pGL3-Basic and the 5'-deleted hST3Gal V promoter without pGL3-177 were transfected into ARPE-19 cells with or without VPA. These results suggest that potential positive regulatory elements exist in pGL3-177 and that the region from -1600 to -177 negatively regulates transcriptional activity. Furthermore, further deletion of nucleotide -83 markedly reduced promoter activity to a level near that of the control vector pGL3-Basic. Therefore, these results clearly suggest that the region containing nucleotides -177 to -83 plays a pivotal role in the expression of the hST3Gal V gene and functions as the VPA-inducible promoter in ARPE-19 cells.
Our previous study (12) showed that that the region from -177 to -83 contains NFY, CREB/ATF, SP1, EGR3, and MZF1 binding sites, although only the CREB/ATF and MZF1 binding sites are present in the correct orientation. Moreover, we also demonstrated that only the consensus CREB/ATF binding site (TGACGTCA) from -143 to -136 is crucial for the TPA-induced expression of hST3Gal V in HL-60 cells (10, 11) . To determine whether or not this CREB/ATF binding site contributes to VPA-induced expression of hST3Gal V in ARPE-19 cells, pGL3-1600mtCREB and pGL3-177mtCREB (10, 11) with CREB/ATF binding site mutations in pGL3-1600 and pGL3-177, respectively, were prepared and transfected into ARPE-19 cells with or without VPA. In VPA-treated ARPE-19 cells, these mutations markedly reduced the transcriptional activity of hST3Gal V (Fig. 3B ). To confirm whether or not CREB or ATF binds to its site in the region from -177 to -83 in the hST3Gal V promoter in ARPE-19 cells, we also performed ChIP assay. Amplification of the hST3Gal V promoter region was carried out in the presence of antibodies specific to CREB, ATF1, and ATF2. As shown in Fig. 3C , only ATF2 demonstrated specific amplification and formed a DNA-protein complex in ARPE-19 cells treated with VPA for regulation of hST3Gal V gene expression. http://bmbreports.org BMB reports There was no detectable binding in the ChIP assay using the CREB and ATF1 antibodies. These results show that hST3Gal V gene expression was modulated by the interaction between the nuclear protein ATF2 and the CREB/ATF element from nucleotide positions -143 to -136. Therefore, this CREB/ATF site is crucial for the VPA-induced expression of hST3Gal V in ARPE-19 cells and the binding of ATF2 to this site is involved in the induction of hST3Gal V gene expression by VPA. Our previous studies have demonstrated that only CREB binding to this site contributes to the promoter activity necessary for high expression of hST3Gal V in VPA-stimulated SK-N-BE(2)-C cells (8) and TPA-induced HL-60 cells (10, 11) . However, in contrast to these findings, our present site-directed mutagenesis and ChIP analyses found that binding of ATF2 to this site mediated VPA-dependent up-regulation of hST3Gal V gene expression in ARPE-19 cells.
Transcriptional activation of hST3Gal V via JNKs pathway in ARPE-19 cells induced by VPA
It has been reported that ATF2 is a phosphorylation target of the c-Jun N-termainal protein kinases (JNKs) signaling pathway, which is activated in response to external signals (13) (14) (15) . Therefore, we investigated whether or not the VPA-induced transcriptional activity of a pGL3-177-containing ATF site is stimulated via the JNK signal pathway. As shown in (Fig. 4B) . However, only JNK inhibitor (SP600125) resulted in a marked decrease in pGL3-177 activity in ARPE-19 cells induced by VPA. These results indicate that the promoter activity and mRNA transcription of the hST3Gal V gene might be regulated by the JNK signaling path-way in VPA-stimulated ARPE-19 cells.
In conclusion, in this study, we showed for the first time that the expression of hST3Gal V mRNA is up-regulated in human retinal pigment epithelial ARPE-19 cells induced by VPA. Furthermore, we demonstrated that VPA treatment markedly increases ganglioside GM3 expression in the membrane fraction of ARPE-19 cells. These results suggest that the induction of hST3Gal V gene expression would direct GM3 biosynthesis in response to VPA in ARPE-19 cells, and that VPA-responsive element(s) exists in the promoter region of the hST3Gal V gene. Although the precise mechanisms involved in the VPA-mediated activation of ATF2 leading to the transcriptional up-regulation of hST3Gal V are unknown, we have demonstrated here for the first time that JNK-dependent ATF2 activation regulates the expression of hST3Gal V in VPA-stimulated ARPE-19 cells.
MATERIALS and METHODS
Cell cultures
The human retinal pigment epithelial cell ARPE-19, obtained from American Type Culture Collection (Manassas, VA, USA) was maintained at 37 o C in a 5% CO2 incubator and cultured initially in a 1：1 mixture of DMEM and Ham F12-medium (DMEM/F12) supplemented with 100 U/ml of penicillin, 100 μg/ml of streptomycin, and 10% (v/v) fetal bovine serum (Gibco BRL, Life Technologies; Grand Island, NY, USA). As an initial experiment, valproic acid (VPA), retinoic acid (RA), fenretinide (FenR), and tetradecanoyl phorbol acetate (TPA), all well-known as inducers of cell differentiation or apoptosis, were used to determine whether or not they modulate the expression of human sialyltransferase genes responsible for ganglioside biosynthesis in ARPE-19 cells.
Analysis of ganglioside GM3 expression levels by VPA
Ganglioside GM3 expression levels were analyzed by the same procedure as described previously (6, 7) . Mouse anti-GM3 monoclonal antibody (mouse IgM, Kappa-chain, clone: GMR6; Seigakagu; Japan) and FITC-conjugated goat-antimouse IgM (Sigma; St. Louis, MO, USA) as the secondary antibody were used to visualize GM3 expression in ARPE-19 cells induced by VPA. The samples were analyzed by confocal laser-scanning microscopy (LSM 510; Zeiss; Jena, Germany).
Reverse transcription-polymerase chain reaction (RT-PCR)
Using Trizol reagent (Invitrogen; Carlsbad, CA, USA), total RNA was isolated from ARPE-19 cells treated with vehicle control or VPA, and 2 μg of RNA was subjected to reverse transcription with random nonamers utilizing a Takara RNA PCR kit (Takara Bio; Shiga, Japan) according to the manufacturer's protocol. The resulting cDNA was amplified by PCR with the following primers: for hST3Gal V (413 bp), 5'-CCCTG CCATTCTGGGTACGAC-3' (sense) and 5'-CACGATCAATGCC TCCACTGAGATC-3' (antisense); hST8Sia I primers (460 bp), 
Transfection and luciferase assay
The luciferase reporter plasmids used herein, namely pGL3-1600 and its derivatives (pGL3-83 to pGL3-1210) with base substitutions in the CREB/ATF binding site, have been described elsewhere (10) (11) (12) . To analyze hST3Gal V promoter activity in response to VPA treatment, ARPE-19 cells (5.0 × 10 4 cells/well) were seeded in 24-well tissue culture plates and allowed to grow to 70% confluence, at which point they were transiently co-transfected with 0.5 μg of the indicated reporter plasmid and 50 ng of the control Renilla luciferase vector pRL-TK (Promega; Madison, WI, USA) using 1 μl of Lipofectamine 2000 (Invitrogen). After a 12-h recovery period in normal medium without VPA, the medium was changed to medium containing 1 mM VPA and incubated for an additional 12 h, after which cells were collected and treated with passive lysis buffer (Promega). Firefly and Renilla luciferase activities were measured using the Dual-Luciferase Reporter Assay System (Promega), according to the manufacturer's instructions, and a GloMax TM 20/20 luminometer (Promega). Firefly luciferase activity of the reporter plasmid was normalized to Renilla luciferase activity and expressed as the fold induction over empty pGL3-Basic vector, which was used as a negative control. Independent triplicate experiments were performed for each plasmid.
Chromatin immunoprecipitation (ChIP) assay
ChIP assay was performed using the ChIP kit (Upstate Biotechnology, NY, USA) following the manufacturer's protocol. Briefly, after treatment with 0 mM or 1 mM VPA for 6 h, ARPE-19 cells (1 × 10 7 cells for one assay) were cross-linked in 1% formaldehyde at room temperature for 10 min to crosslink the proteins and DNAs, followed by sonication to shear the DNAs to an average size of 200-1,000 bp. Immunoprecipitation was carried out using 10 μg of CREB, ATF1, and ATF2 antibodies (Santa Cruz Biotechnology, CA, USA). After reversal of cross-linking, the DNA fragments were purified by phenol extraction and ethanol precipitation, followed by PCR analysis using primers flanking the CREB/ATF binding sites in the hST3Gal V promoter: 5'-GCCCCGGGTGCGTCCCTG-3' (forward) and 5'-AGCGCCGCTCTCGCGCC-3' (reverse).
